Lantern Pharma, Inc. (LTRN)

3.31 -0.07 (-2.07%) USD  |  NASDAQ  |  May 27, 16:00
3.32 +0.01 (+0.30%) After-Hours: 20:00
More

Lantern Pharma Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for LTRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
BioVie, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Spero Therapeutics, Inc. Upgrade
Replimune Group, Inc. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade